Amyloid-β-laden CSF turns guardian macrophages into collateral damage in Alzheimer's disease | Synapse
June 7, 2026
Amyloid-β-laden CSF turns guardian macrophages into collateral damage in Alzheimer's disease
Key Points
This commentary discusses the implications of amyloid-β's effects on macrophages in Alzheimer's disease by referencing a study on glymphatic failure.
Analysis of findings from Liu et al. regarding glymphatic failure in specific mouse models.
Discussion on the role of border macrophages in brain health and Alzheimer's pathology.
Identifies a correlation between amyloid-β presence and loss of parenchymal border macrophages.
Suggests that early glymphatic failure could lead to significant macrophage dysfunction in Alzheimer's disease.
Abstract
This scientific commentary refers to ‘Early glymphatic failure in AppNL-F knock-in mice is linked to parenchymal border macrophages loss’ by Liu et al. (https://doi.org/10.1093/brain/awag080).